Contact me to get the spreadsheet with full data I used for my analysis. As a CEO of an early-stage biotech company (Neurolentech) operating in the spaceof neurodevelopmental diseases (NDDs), I spend a significant part...read more
Features and insights
2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….
2023 was quite year, to say the least! Among the things that we witnessed: The second biggest bank collapse in US history, layoffs across biotech, AI/ChatGPT dominated the scene, AlphaFold received the Lasker price...read more
L7 Informatics Manages and Supports the Entire Lab Workflow from Sample Processing to Data Analysis and Insight Generation Employing Workflow Orchestration
The Result Is An Automated, Highly Efficient, and Cost Effective Lab Management Process This month’s “Company Spotlight” provides a closer look at L7 Informatics, the provider of a scientific process and data management...read more
Changing the Clinical Genetic Testing Paradigm to Increase Sensitivity and Specificity
The goal of clinical genomics is to provide a diagnosis for difficult-to-solve inherited and somatic disorders to enhance a personalized therapeutic approach. Unfortunately, despite costly and extensive testing only...read more
Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine
My most recent interview is with Gavin Nichols, the CEO of the newly formed company Velsera. Velsera launched in January 2023, after quietly acquiring the three companies Seven Bridges, UgenTec, and Pierian in mid...read more
The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”
We may still be five Years out until We Can Sequence Everyone I had the chance to attend the Precision Medicine World Conference PMWC 2023 SV in the last couple of days. Some 2,000+ individuals from across the life...read more
ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists
This month’s “Company Spotlight” provides a closer look at ONTOFORCE, the creator of a semantic search technology platform for insight generation. I spoke with Valerie Morel, CEO of ONTOFORCE, about ONTOFORCE’s platform...read more
Time Is What We Want Most – Why Wasting Any More of It?
As many of us continuously experience, combing through the latest news in any scientific research area or a given commercial sector – whether it is to stay up-to-date in a specific field, view the latest trends in...read more
Omicron NTD Insertions: A new Route for Variant Generation?
My most recent article published was a quick review of what was known about the SARS Omicron variant in the post 2021, The Year of the Various SARS-CoV-2 Variants of Concern – from Alpha to Omicron. While researching...read more
We Invite you to join enlightenbio’s Subject Matter Expert Network!
enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more
